-
EMG’s Canadian Chapter – Published in the Wolters Kluwer’s “Guide to International Transfer Pricing: Law, Tax Planning and Compliance Strategies”
EMG has contributed their 3rd installment of the Canadian chapter (Chapter 7) in the Kluwer Publication.
By Merv Edwards and Dean Morris, published in the Wolters Kluwer’s “Guide to International Transfer Pricing: Law, Tax Planning and Compliance Strategies” book.
-
EMG Summary of GlaxoSmithKline
Canada’s Never-Ending Transfer Pricing DisputeBetween 1990 and 1993, GlaxoSmithKline Inc. (“Glaxo Canada”) purchased ranitidine, the active pharmaceutical ingredient in the brand name anti-ulcer blockbuster drug Zantac, from Adechsa S.A., a related non-resident company, for between $1,512 and $1,651 per kilogram. During the same period, two Canadian generic pharmaceutical companies, Apotex Inc. (“Apotex”) and Novopharm Ltd. (“Novopharm”) purchased ranitidine from other sources for use in their generic anti-ulcer drugs for between $194 and $304 per kilogram from arm’s length suppliers.
 |
Expert Transfer Pricing Services From Root To Branch |